Haemonetics (HAE) PT Raised to $77 at Morgan Stanley
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $90.66 -0.74%
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Morgan Stanley raised its price target on Haemonetics (NYSE: HAE) to $77.00 (from $74.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- JPMorgan Downgrades Denso Corp. (6902:JP) (DNZOY) to Underweight
- Medipal Holdings Corp (7459:JP) PT Lowered to JPY3,080 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
